High dose epirubicin and cyclophosphamide (EC) vs cyclophosphamide, methotrexate, fluorouracil (CMF) as adjuvant chemotherapy in high risk premenopausal breast cancer patients (PTS). A prospective randomized trial

被引：0
|
作者：
Galligioni, E [1 ]
Cetto, G [1 ]
Nascimben, O [1 ]
Buonadaona, A [1 ]
Crivellari, D [1 ]
Molino, A [1 ]
Veronesi, A [1 ]
Graiff, C [1 ]
Barni, S [1 ]
Puccetti, C [1 ]
Ferrazzi, E [1 ]
Recaldin, E [1 ]
Sava, C [1 ]
Saracchini, S [1 ]
Sacco, C [1 ]
机构：
[1] Ctr Riferimento Oncol, GOCCNE, I-33081 Aviano, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(97)89301-X
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P84
引用
收藏
页码：S36 / S36
页数：1
相关论文
共 50 条
  • [1] CONTROLLED TRIAL OF ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE METHOTREXATE AND FLUOROURACIL (CMF) FOR BREAST-CANCER
    HOWELL, A
    BUSH, H
    GEORGE, WD
    HOWAT, JMT
    CROWTHER, D
    SELLWOOD, RA
    RUBENS, RD
    HAYWARD, JL
    BULBROOK, RD
    FENTIMAN, IS
    CHAUDARY, M
    BRITISH JOURNAL OF CANCER, 1984, 50 (02) : 253 - 253
  • [2] Prospective meta-analysis of randomised trials of cyclophosphamide, methotrexate & fluorouracil (CMF) vs fluorouracil, epirubicin & cyclophosphamide (FEC) chemotherapy in early breast cancer
    Marty, ME
    Coombes, RC
    Peckitt, C
    López, FRP
    Tres, A
    Morvan, F
    Tubiana-Mathieu, N
    Espié, M
    Bliss, JM
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 25S - 25S
  • [3] Adjuvant cyclophosphamide, methotrexate, and fluorouracil versus fluorouracil, epirubicin, and cyclophosphamide chemotherapy in premenopausal women with axillary node-positive operable breast cancer: Results of a randomized trial
    Coombes, RC
    Bliss, JM
    Wils, J
    Morvan, F
    Espie, M
    Amadori, D
    Gambrosier, P
    Richards, M
    Aapro, M
    VillarGrimalt, A
    McArdle, C
    PerezLopez, FR
    Vassilopoulos, P
    Ferreira, EP
    Chilvers, CED
    Coombes, G
    Woods, EM
    Marty, M
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (01) : 35 - 45
  • [4] Cyclophosphamide, Methotrexate, and Fluorouracil; Oral Cyclophosphamide; Levamisole; or No Adjuvant Therapy for Patients With High-Risk, Premenopausal Breast Cancer
    Ejlertsen, Bent
    Mouridsen, Henning T.
    Jensen, Maj-Britt
    Andersen, Jorn
    Andersson, Michael
    Kamby, Claus
    Knoop, Ann S.
    CANCER, 2010, 116 (09) : 2081 - 2089
  • [5] Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer
    Levine, MN
    Bramwell, VH
    Pritchard, KI
    Norris, BD
    Shepherd, LE
    Abu-Zahra, H
    Findlay, B
    Warr, D
    Bowman, D
    Myles, J
    Arnold, A
    Vandenberg, T
    MacKenzie, R
    Robert, J
    Ottaway, J
    Burnell, M
    Williams, CK
    Tu, DS
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2651 - 2658
  • [6] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Kimura, Morihiko
    Tominaga, Takeshi
    Takatsuka, Yuichi
    Toi, Masakazu
    Abe, Rikiya
    Koyama, Hiroki
    Takashima, Shigemitsu
    Nomura, Yasuo
    Miura, Shigeto
    Kimijima, Izo
    Tashiro, Hideya
    Ohashi, Yasuo
    BREAST CANCER, 2010, 17 (03) : 190 - 198
  • [7] Randomized trial of cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil with node-positive breast cancer in Japan
    Morihiko Kimura
    Takeshi Tominaga
    Yuichi Takatsuka
    Masakazu Toi
    Rikiya Abe
    Hiroki Koyama
    Shigemitsu Takashima
    Yasuo Nomura
    Shigeto Miura
    Izo Kimijima
    Hideya Tashiro
    Yasuo Ohashi
    Breast Cancer, 2010, 17 : 190 - 198
  • [8] Randomised adjuvant trial comparing two dose intensities of epirubicin and cyclophosphamide (EC) in high-risk breast cancer
    Konecny, G
    Thomssen, C
    Untch, M
    Kahlert, S
    Kuhn, W
    Sattler, D
    Piche, E
    Lebeau, A
    Dettmar, P
    Graeff, H
    Jänicke, F
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S41 - S41
  • [9] Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma
    Cocconi, G
    Di Blasio, B
    Boni, C
    Bisagni, G
    Ceci, G
    Rondini, E
    Bella, M
    Leonardi, F
    Savoldi, L
    Camisa, R
    Bruzzi, P
    CANCER, 2002, 95 (02) : 228 - 235
  • [10] ADJUVANT CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE AND FLUOROURACIL (CMF) IN EARLY BREAST-CANCER - MECHANISMS OF ACTION
    PADMANABHAN, N
    HOWELL, A
    RUBENS, RD
    BRITISH JOURNAL OF CANCER, 1986, 53 (03) : 431 - 432
12345